Bridgepoint-backed Prescient has acquired Uptake Strategies, a global healthcare consultancy. This strategic M&A move expands Prescient's service offerings within the life sciences sector. The acquisition enhances Prescient's capabilities in healthcare consulting, allowing it to provide more comprehensive solutions to pharmaceutical and biotech clients.

For the private equity landscape, this deal highlights ongoing consolidation trends where portfolio companies actively pursue bolt-on acquisitions to drive growth and market share. The partnership with Bridgepoint, a major private equity firm, provides the capital and strategic guidance necessary for such expansions. This transaction underscores the high value placed on specialized healthcare consultancies and signals continued investment activity in the life sciences services vertical.

The integration of Uptake's expertise will likely strengthen Prescient's competitive positioning against larger CROs and consulting networks.